Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Expert Analyses of the following article:

FDA Approves Luvox CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder and Obsessive Compulsive Disorder

Source: pharmalive.com
March 11, 2008
Luvox CR (Jazz Pharm. - Nasdaq: JAZZ) Will Drive OCD/SAD Sufferers to Treatment
Author: GLG Expert Contributor
OCD (Obsessive Compulsive Disorder) and SAD (Social Anxiety Disorder) are two of the more common...much more common than formerly thought...diagnoses and also two of the most difficult to treat.  JAZZ Pharmaceutical's new fluvoxamine formulation (Luvox CR) will invigorate patient self-identification and treatment of these disorders.
March 7, 2008
Exciting new treatment for OCD and Social Anxiety Disorder
Author: GLG Expert Contributor
1. Controlled release preparations are often better tolerated with fewer side effects than immediate release preparations 2. OCD and SAD are severe, highly prevalent and chronically disabling conditions 3. Despite presence of SSRIs and other treatment, e.g, cognitive behavioral therapy, up to 1/3 of patients with OCD or SAD do not respond to currently available treatments and among responders many...
March 6, 2008
FDA approval of Luvox CR is good news for psychiatrists!
Author: GLG Expert Contributor
Luvox was one of the first SSRI's approved for pediatric prescription (for OCD rather than for depression). When patent expired, the maker discontinued manufacture. It has been available in limited supply as generic. Availability of brand-name extended-release product (Luvox CR) will be a significant addition to the options for drug treatment of anxiety disorders in children and adolescents, since...
March 5, 2008
Luvox CR Approved for OCD and Social Anxiety--Where's the Beef?
Author: GLG Expert Contributor
Fluovoxamine is perhaps the last participant in the SSRI explosion of the 1980's.  It is also the least used and hence, least profitable entry in the SSRI horse race, primarily because of timing rather than any particular pharmacological deficiency.  To believe that this attempt to rejuvenate an old draught horse is likely to lead to winning any trophies is pretty naive, in my opinion. ...
Louis SanfilippoMarch 5, 2008
An Uphill Battle Ahead – Luvox CR Approved for OCD and Social Anxiety
Author: Louis Sanfilippo, MD, President, LCS Group, LLC
Fluvoxamine, the least known of the selective serotonin reuptake inhibitors in the US, will now have an FDA approved controlled release version - Luvox CR - for the treatment of OCD and Social Anxiety Disorder.   The collaboration between Jazz Pharmaceuticals and Solvay will have only an uphill battle ahead to improve perception of the fluvoxamine/Luvox line.  The Luvox brand once had...

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-11-21T17:45:19.123